81 studies found for:    "Acute erythroleukemia" "Acute erythroid leukemia"
Show Display Options
Rank Status Study
21 Completed Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: etoposide;   Procedure: autologous bone marrow transplantation
22 Completed Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: cytarabine;   Drug: methotrexate;   Procedure: allogeneic bone marrow transplantation;   Procedure: syngeneic bone marrow transplantation
23 Completed Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: carboplatin;   Drug: fludarabine phosphate;   Drug: topotecan hydrochloride
24 Completed Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Biological: filgrastim;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: fludarabine phosphate;   Drug: tretinoin
25 Completed Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Conditions: Graft Versus Host Disease;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclosporine;   Drug: melphalan;   Drug: methylprednisolone;   Procedure: umbilical cord blood transplantation;   Radiation: radiation therapy
26 Completed Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Drug: Cyclophosphamide;   Drug: Psoralen;   Drug: Thiotepa;   Procedure: Allogeneic bone marrow transplantation;   Procedure: In vitro-treated peripheral blood stem cell transplantation (PBSCT);   Radiation: Radiation Therapy (RT)
27 Completed Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Biological: anti-thymocyte globulin;   Biological: graft-versus-tumor induction therapy;   Drug: cyclophosphamide;   Drug: melphalan;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
28 Unknown  Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Condition: Leukemia
Interventions: Biological: recombinant interferon alfa;   Drug: amifostine trihydrate;   Drug: bromodeoxyuridine;   Drug: cytarabine;   Drug: idarubicin;   Drug: idoxuridine;   Drug: isotretinoin;   Drug: mitoxantrone hydrochloride
29 Unknown  Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: idarubicin;   Procedure: allogeneic bone marrow transplantation;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
30 Completed Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: clofarabine;   Drug: cyclophosphamide
31 Recruiting Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous Condition;   Secondary Myelofibrosis
Interventions: Drug: Busulfan;   Drug: Cytarabine;   Drug: Fludarabine phosphate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
32 Active, not recruiting Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: gemtuzumab ozogamicin;   Drug: mitoxantrone hydrochloride
33 Unknown  Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
Conditions: Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Biological: anti-thymocyte globulin;   Biological: donor lymphocytes;   Biological: filgrastim;   Biological: therapeutic allogeneic lymphocytes;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Other: pharmacological study;   Other: reduced-intensity transplant conditioning procedure;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation
34 Unknown  Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Condition: Leukemia
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methotrexate;   Procedure: allogeneic hematopoietic stem cell transplantation
35 Unknown  Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: cyclophosphamide;   Procedure: in vitro-treated bone marrow transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation
36 Active, not recruiting
Has Results
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: clofarabine;   Drug: cytarabine;   Drug: methotrexate;   Other: laboratory biomarker analysis
37 Unknown  Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
Condition: Leukemia
Interventions: Genetic: DNA analysis;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
38 Completed Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: umbilical cord blood transplantation;   Drug: methylprednisolone
39 Active, not recruiting S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy
Condition: Leukemia
Interventions: Genetic: proteomic profiling;   Other: flow cytometry;   Other: laboratory biomarker analysis
40 Completed Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
Condition: Leukemia
Interventions: Drug: ara-C;   Drug: Daunorubicin;   Drug: Etoposide;   Drug: PSC-833;   Biological: Aldesleukin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years